Back to Results
First PageMeta Content
Melanoma / Immunotherapy / Cancer immunotherapy / Cancer research / Fred Hutchinson Cancer Research Center / CancerVax / Medicine / Cancer organizations / Cancer treatments


FOR IMMEDIATE RELEASE April 25, 2012 Dean Forbes – Media Relations Fred Hutchinson Cancer Research Center[removed]CANCER IMMUNOTHERAPY TRIALS NETWORK INVESTIGATOR, AWARDED GRANT BY
Add to Reading List

Document Date: 2013-11-15 15:23:52

Open Document

File Size: 361,47 KB

Share Result on Facebook

Company

Altor BioSciences / /

Event

FDA Phase / /

Facility

University of Washington / Receptor-IgFc Complex / Milken Institute / /

IndustryTerm

cross-disciplinary / treatment of patients with Acute Respiratory Distress Syndrome / biotechnology company developing immunotherapies / other cancer therapies / technology platforms / treatment of patients with metastatic melanoma / /

MedicalCondition

Acute Lung Injury / cancer / metastatic urothelial cancer / systemic inflammatory disease / Acute Respiratory Distress Syndrome / solid tumors / advanced melanoma / viral infections / melanoma / incurable melanoma / inflammatory diseases / metastatic melanoma / /

MedicalTreatment

immunotherapies / cancer therapies / immunotherapy / /

Organization

University of Washington / Media Relations Fred Hutchinson Cancer Research Center / Melanoma Research Alliance / Milken Institute / Fred Hutchinson Cancer Research Center / /

Person

Leon Black / AWARDED GRANT BY MELANOMA / Debra Black / Kim Margolin / Dean Forbes / /

/

Position

IMMUNOTHERAPY TRIALS NETWORK INVESTIGATOR / co-principal investigator / Professor of Medicine / /

Product

ALT-836 / /

Technology

biotechnology / /

URL

www.curemelanoma.org / www.altorbioscience.com / www.CITNinfo.org / /

SocialTag